SomaLogic boasts industry-leading reliability metrics that include sensitivity, specificity, and reproducibility.Ìý

The University of Colorado Connection

Professor Larry Gold (CU Boulder MCDB) founded SomaLogic, which pioneered the development of proteomics diagnostics and assays based on Gold’s SELEX technology. After going public in 2021, SomaLogic announced a merger with .

Funding Status and Investment Opportunities

  • Industry: Biotech​, Genomics, Health and Wellness​, Therapeutics, Diagnostics
  • Funding Stage: Exit
  • Contact for Investment Inquiries: Standard Bio Tools Inc. (LAB)

Venture Partners Programs​

Path to Commercialization


ÌýÌýThis page was last updated Sept. 3, 2024. Please contact us for corrections or updates